- Industrial company Johnson Controls (NYSE:JCI) has announced a joint development agreement with and a strategic investment in biotechnology company Phylagen.
- Phylagen is an expert in the field of microbiome optimization of indoor environments. As part of the agreement, the companies will jointly develop innovative technology that leverages the science of building microbiomes to advance the future of healthy buildings.
- Additionally, Johnson Controls will make a strategic investment in Phylagen.
- JCI +1.23% pre-market
- Recently, Morgan Stanley coined Johnson Controls as its favored pick in the (HVAC) sector, citing secular trends around efficiency and air quality combined with a cyclical uptick in non-residential to set up accelerating growth.